Last reviewed · How we verify
NCT07312838
Evaluation of Glycemic Impact on Fetal Liver Length and Volume by Ultrasound in Pregnancy
trial in Gestatiaonl Diabetes Mellitus in 115 participants. Not yet recruiting.
28 March 2028
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 115 |
| Start date | 1 January 2026 |
| Primary completion | 28 March 2028 |
| Estimated completion | 28 March 2028 |
Conditions studied
- Gestatiaonl Diabetes Mellitus — all drugs for Gestatiaonl Diabetes Mellitus →
- FETAL LİVER VOLUME — all drugs for FETAL LİVER VOLUME →
Sponsor
Assiut University
Who can join
Adults 18 to 52, female only, with Gestatiaonl Diabetes Mellitus or FETAL LİVER VOLUME. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of this study is to evaluate whether fetal liver length and volume, as assessed by ultrasound, can serve as reliable markers of the metabolic impact of Gestational Diabetes Mellitus (GDM) on the fetus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07312838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestatiaonl Diabetes Mellitus
Currently open trials in the same condition.
- NCT07161947 — Shanghai Clinical Cohort of Hyperglycemia in Pregnancy · recruiting
- NCT07125885 — Gongji Pregnancy Endorine Cohort Study · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07312838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 31 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07312838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing